Volver al ranking

Thumbnails similares a GLP-1s Move Beyond Diabetes as Core Kidney-Protective Therapy

20 vecinos (thumb_512) · 80 views · HCPLive · Estados Unidos

GLP-1s Move Beyond Diabetes as Core Kidney-Protective Therapy

HCPLive

@hcplivenews

80Estados Unidos
10Beyond Atherosclerosis: Coronary Calcium Scoring in Dyslipidemia, CKM Syndrome

HCPLive

@hcplivenews

2.0KEstados Unidos68
18Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D

HCPLive

@hcplivenews

1.6KEstados Unidos67
3Why Glucose Alone Isn't Enough: The Future of Ketone Monitoring in Diabetes

HCPLive

@hcplivenews

475Estados Unidos74
15Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026

HCPLive

@hcplivenews

301Estados Unidos67
20Dietary Interventions to Slow Metabolic Deterioration in Menopausal Patients

HCPLive

@hcplivenews

175Estados Unidos66
1GLP-1 Receptor Agonists Reshape CKD Treatment Sequencing, With Pranav Garimella, MD

HCPLive

@hcplivenews

151Estados Unidos80
2FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD

HCPLive

@hcplivenews

131Estados Unidos74
16VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes

HCPLive

@hcplivenews

96Estados Unidos67
5Improving GLP-1 Adherence in Patients With Diabetes, With Vivian Fonseca, MD

HCPLive

@hcplivenews

91Estados Unidos73
11How a Nephrologist Diagnoses and Manages Chronic Kidney Disease

HCPLive

@hcplivenews

70Estados Unidos68
7Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD

HCPLive

@hcplivenews

68Estados Unidos71
19Omalizumab vs Oral Immunotherapy for Multifood Allergy

HCPLive

@hcplivenews

65Estados Unidos66
4GLP-1 Discontinuation in Type 2 Diabetes: What Happens When Patients Stop?

HCPLive

@hcplivenews

64Estados Unidos73
9SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026

HCPLive

@hcplivenews

48Estados Unidos69
13Screening for Type 1 Diabetes in Adults: What Needs to Change

HCPLive

@hcplivenews

42Estados Unidos67
12Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data

HCPLive

@hcplivenews

27Estados Unidos67
17B-Cell–Targeted Therapies Expand in IgA Nephropathy, With Samir Parikh, MD

HCPLive

@hcplivenews

27Estados Unidos67
6Does Insulin Resistance Harm the Lungs? CT Data Offers New Clues | ATS 2026

HCPLive

@hcplivenews

25Estados Unidos72
14What's Next for Peanut Allergy Microneedle Immunotherapy, With Brian Vickery, MD

HCPLive

@hcplivenews

12Estados Unidos67
8Key Diagnostic and Therapeutic Pearls for Connective Tissue Disease, With Michelle Min, MD

HCPLive

@hcplivenews

8Estados Unidos69